Signalling molecule
Interleukin-22
An immune signalling molecule implicated in epidermal barrier recovery after microinjury
Hypotheses on this target 1
Lower level
Synthesis suppression
Neutralisation1
Supplementation
Accelerated excretion
Neutralisation1
Skin lipids may slow repair by blocking immune recognition and its repair signal
Where this hypothesis actsHuman skin after stress and brief activation of autologous CD1a-reactive T cells
What is proposedBlock interleukin-22 to test whether it mediates restored barrier recovery
With whatNot stated in the record
HowInterleukin-22 blockade after T-cell activation; the blocking agent is not stated
Possible resultExpected loss of the recovery restored by T-cell activation
2026-09-26